American Journal of Transplantation

Papers
(The H4-Index of American Journal of Transplantation is 68. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Morning Administration Enhances Humoral Response to SARS-CoV-2 Vaccination in Kidney Transplant Recipients875376689
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter612
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection419
COVID-19 in solid organ transplant recipients: A single-center case series from Spain324
COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium286
OPTN/SRTR 2019 Annual Data Report: Kidney273
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus273
Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression234
OPTN/SRTR 2019 Annual Data Report: Liver228
OPTN/SRTR 2020 Annual Data Report: Liver205
Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?200
First clinical-grade porcine kidney xenotransplant using a human decedent model196
COVID-19 in kidney transplant recipients189
Early impact of COVID-19 on transplant center practices and policies in the United States187
Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020186
Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients186
OPTN/SRTR 2020 Annual Data Report: Kidney185
Is COVID-19 infection more severe in kidney transplant recipients?174
COVID-19: A global transplant perspective on successfully navigating a pandemic170
COVID-19 in kidney transplant recipients154
Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: Potential role of ferroptosis143
COVID-19 in transplant recipients: The Spanish experience135
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation131
Coronavirus disease 2019: Implications of emerging infections for transplantation128
The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs123
OPTN/SRTR 2019 Annual Data Report: Lung122
SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England: A national cohort study120
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients116
Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation–Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation114
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients110
Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study110
A change of heart: Preliminary results of the US 2018 adult heart allocation revision109
Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients107
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients107
OPTN/SRTR 2020 Annual Data Report: Heart106
Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing103
Impact of COVID-19 in solid organ transplant recipients95
COVID-19 in posttransplant patients—report of 2 cases94
COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination — United States, September and December 202093
Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients92
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study91
Potential indirect effects of the COVID-19 pandemic on use of emergency departments for acute life-threatening conditions — United States, January–May 202089
Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve89
Maintaining the permanence principle for death during in situ normothermic regional perfusion for donation after circulatory death organ recovery: A United Kingdom and Canadian proposal89
OPTN/SRTR 2019 Annual Data Report: Heart89
Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients87
Long-term kidney transplant graft survival—Making progress when most needed84
Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach82
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept82
Liver transplantation for critically ill cirrhotic patients: Stratifying utility based on pretransplant factors81
Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States81
High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury81
Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review80
Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave79
Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient?77
Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients76
Decline in child vaccination coverage during the COVID-19 pandemic — Michigan Care Improvement Registry, May 2016-May 202075
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients75
Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience74
OPTN/SRTR 2020 Annual Data Report: Lung74
A systematic review and meta-analysis of COVID-19 in kidney transplant recipients: Lessons to be learned74
COVID-19 in Spain: Transplantation in the midst of the pandemic73
Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study73
Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States73
COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine70
Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients70
Use of SARS-CoV-2-infected deceased organ donors: Should we always “just say no?”69
Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report68
SARS Cov-2 infection in a renal-transplanted patient: A case report68
0.044296979904175